 |
|
|
| |
C-EDGE Co-Infected: final results from Phase 3
Study of elbasvir / grazoprevir in Patients with HCV/HIV
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Jürgen K. Rockstroh, Mark Nelson, Christine Katlama, Jay Lalezari, Josep Mallolas, Mark Bloch, Gail Matthews, Michael S. Saag, Philippe Zamor, Chloe Orkin, Jacqueline Gress, Melissa Shaughnessy, Stephanie Klopfer, Janice Wahl, Bach-Yen Nguyen, Eliav Barr, Heather L. Platt, Michael Robertson, Mark Sulkowski
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial - (07/10/15)
|
| |
|
|
|
|
|
